ATE394097T1 - Verfahren zur verabreichung von buprenorphin zur behandlung von depression - Google Patents
Verfahren zur verabreichung von buprenorphin zur behandlung von depressionInfo
- Publication number
- ATE394097T1 ATE394097T1 AT03721427T AT03721427T ATE394097T1 AT E394097 T1 ATE394097 T1 AT E394097T1 AT 03721427 T AT03721427 T AT 03721427T AT 03721427 T AT03721427 T AT 03721427T AT E394097 T1 ATE394097 T1 AT E394097T1
- Authority
- AT
- Austria
- Prior art keywords
- depression
- buprenorphine
- administration
- treatment
- patients suffering
- Prior art date
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title abstract 4
- 229960001736 buprenorphine Drugs 0.000 title abstract 4
- 208000020401 Depressive disease Diseases 0.000 title 1
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36635802P | 2002-03-20 | 2002-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE394097T1 true ATE394097T1 (de) | 2008-05-15 |
Family
ID=28454789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03721427T ATE394097T1 (de) | 2002-03-20 | 2003-03-20 | Verfahren zur verabreichung von buprenorphin zur behandlung von depression |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030181475A1 (https=) |
| EP (1) | EP1485051B1 (https=) |
| JP (1) | JP2005528359A (https=) |
| AT (1) | ATE394097T1 (https=) |
| AU (1) | AU2003224742A1 (https=) |
| CY (1) | CY1108217T1 (https=) |
| DE (1) | DE60320770D1 (https=) |
| DK (1) | DK1485051T3 (https=) |
| ES (1) | ES2305457T3 (https=) |
| PT (1) | PT1485051E (https=) |
| SI (1) | SI1485051T1 (https=) |
| WO (1) | WO2003079945A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DK1572167T3 (da) | 2002-12-13 | 2008-10-13 | Euro Celtique Sa | Transdermal buprenophindoseringsbehandlingsplan for analgesi |
| EP1913938A1 (en) * | 2002-12-13 | 2008-04-23 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| RS20050812A (sr) | 2003-04-30 | 2007-12-31 | Purdue Pharma L.P., | Transdermalni dozni oblik otporan na promene |
| US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| ATE375149T1 (de) | 2003-07-25 | 2007-10-15 | Euro Celtique Sa | Behandlung von entzug |
| DE10340428B4 (de) * | 2003-09-02 | 2015-02-12 | Acino Ag | Opioides Analgetikum enthaltende transdermale Formulierung |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
| DE102004045599A1 (de) * | 2004-09-17 | 2006-03-23 | Grünenthal GmbH | System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen |
| DE102005007859A1 (de) * | 2005-02-21 | 2006-08-24 | Lts Lohmann Therapie-Systeme Ag | Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen |
| DE102006011340A1 (de) * | 2006-03-09 | 2007-09-20 | Grünenthal GmbH | Wirkstoffhaltige Pflaster mit verbesserter Handhabung |
| US9119848B2 (en) | 2009-12-04 | 2015-09-01 | Alkermes Pharma Ireland Limited | Morphinan derivatives for the treatment of drug overdose |
| HUE065427T2 (hu) | 2010-08-23 | 2024-05-28 | Alkermes Pharma Ireland Ltd | Eljárások antipszichotikum által indukált súlygyarapodás kezelésére |
| WO2013042054A1 (en) * | 2011-09-19 | 2013-03-28 | Carmel - Haifa University Economic Corporation Ltd. | Buprenorphine for the treatment of acute suicidality |
| US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| EP2790703B1 (en) * | 2011-12-15 | 2019-06-12 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with opioid agonists |
| US10195191B2 (en) | 2011-12-15 | 2019-02-05 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| MX375348B (es) * | 2011-12-15 | 2025-03-06 | Alkermes Pharma Ireland Ltd | Composiciones de la buprenorfina y antagonistas de los receptores opioide-mu. |
| EP3003311A2 (en) | 2013-05-24 | 2016-04-13 | Alkermes Pharma Ireland Limited | Methods for treating depressive symptoms |
| CA2911231C (en) | 2013-05-24 | 2021-12-07 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
| MX368870B (es) * | 2013-12-20 | 2019-10-21 | H Lundbeck As | Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas. |
| WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| EP0484543B1 (en) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| JP4086317B2 (ja) * | 1996-03-25 | 2008-05-14 | エルティエス ローマン テラピー―ズュステーメ アーゲー | 塗布領域の厚さが薄く柔軟性が高い経皮治療システムおよびその製造方法 |
| US6787149B1 (en) * | 1996-12-12 | 2004-09-07 | El Khoury And Stein Ltd. | Topical application of opioid analgesic drugs such as morphine |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| DE19738855C2 (de) * | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
| DE19746191C2 (de) * | 1997-10-18 | 2000-05-18 | Lohmann Therapie Syst Lts | Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht |
| EP1061924A1 (en) * | 1998-03-09 | 2000-12-27 | Trustees Of Tufts College | Treatment of compulsive behaviours in man and animals |
| DE19840758A1 (de) * | 1998-09-07 | 2000-03-09 | Liedtke Pharmed Gmbh | Systemische Therapie von Schmerz- und depressiver Befindlichkeit |
-
2003
- 2003-03-20 AU AU2003224742A patent/AU2003224742A1/en not_active Abandoned
- 2003-03-20 AT AT03721427T patent/ATE394097T1/de active
- 2003-03-20 DE DE60320770T patent/DE60320770D1/de not_active Expired - Lifetime
- 2003-03-20 SI SI200331272T patent/SI1485051T1/sl unknown
- 2003-03-20 EP EP03721427A patent/EP1485051B1/en not_active Expired - Lifetime
- 2003-03-20 US US10/394,425 patent/US20030181475A1/en not_active Abandoned
- 2003-03-20 JP JP2003577780A patent/JP2005528359A/ja active Pending
- 2003-03-20 DK DK03721427T patent/DK1485051T3/da active
- 2003-03-20 PT PT03721427T patent/PT1485051E/pt unknown
- 2003-03-20 ES ES03721427T patent/ES2305457T3/es not_active Expired - Lifetime
- 2003-03-20 WO PCT/US2003/008796 patent/WO2003079945A1/en not_active Ceased
-
2008
- 2008-07-28 CY CY20081100780T patent/CY1108217T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1485051T1 (sl) | 2008-10-31 |
| EP1485051A1 (en) | 2004-12-15 |
| ES2305457T3 (es) | 2008-11-01 |
| WO2003079945A1 (en) | 2003-10-02 |
| EP1485051B1 (en) | 2008-05-07 |
| DK1485051T3 (da) | 2008-09-08 |
| DE60320770D1 (de) | 2008-06-19 |
| EP1485051A4 (en) | 2006-05-24 |
| JP2005528359A (ja) | 2005-09-22 |
| AU2003224742A1 (en) | 2003-10-08 |
| US20030181475A1 (en) | 2003-09-25 |
| PT1485051E (pt) | 2008-07-09 |
| CY1108217T1 (el) | 2014-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108217T1 (el) | Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης | |
| CY1107262T1 (el) | Θεραπεια της εξαρτησης στερησης | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE380548T1 (de) | Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie | |
| ATE265213T1 (de) | Noribogain zur behandlung von schmerzen und drogenabhängigkeit | |
| CY1107352T1 (el) | Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου | |
| ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| ATE310509T1 (de) | Methode zur behandlung eines analgesiebedürftigen patienten | |
| ATE484280T1 (de) | Verwendung der kombination aus temozolomid und tnf-alpha zur behandlung von glioblastoma | |
| ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| EP1795189A3 (en) | Method of administering buprenorphine to treat depression | |
| DE60316927D1 (de) | Verwendung von devazepide als schmerzmittel | |
| Sharaf El-Din et al. | Pulsed electromagnetic field (PEMF): Effective adjuvant therapy in venous and vasculitic leg ulcers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1485051 Country of ref document: EP |